All News

While these drugs can help prevent breast cancer, they also carry the risk of serious complications and affect a patient's quality of life. Three experts offer advice on how to manage these problems.

With no reliable screening tests available, ob/gyns have tried to use their clinical judgment and the patient's medical history to detect the disease in its early stages. Recent studies have found, however, that a specific set of persistent signs and symptoms may signal emerging disease and warrant follow-up diagnostic testing.

Choosing the best Republican presidential candidate requires a closer look at their stand on professional liability and reproductive rights.

With no clear-cut set of signs and symptoms to advertise its presence, experts suggest diagnosis may require MRI, transvaginal U/S, and/or needle biopsy. Among your treatment options: hysterectomy, GnRH agonists, and the levonorgestrel IUD.

How do you and your depressed patients walk that fine line between the risks of taking-or not taking-antidepressants during pregnancy? Which drugs or alternate therapies seem safest? An expert cautions that maternal and fetal risks of untreated mental illness-ranging from spontaneous abortion to suicide-may outweigh the risks of antidepressants.

Given the increased risks inherent during VBAC, ob/gyns must take great care to ensure that all of the caregivers involved in the trial of labor are on the same page.

Dr. Charles Lockwood outlines the Democratic candidates and where they stand on health-care reform, tort reform, and reproductive rights.

Treat your nonpregnant patient with one of these drug regimens to reduce out-of-control blood loss while she's waiting for the operating room-and she may not need surgery to stop hemorrhage, after all, says this expert. Noting that our standard treatments for this challenging, often overlooked emergency are based on scant data, he assesses your options.

Treat your nonpregnant patient with one of these drug regimens to reduce out-of-control blood loss while she's waiting for the operating room-and she may not need surgery to stop hemorrhage, after all, says this expert. Noting that our standard treatments for this challenging, often overlooked emergency are based on scant data, he assesses your options.

Dr. Chan argues that repairing all clinically significant varicoceles can at least enhance semen parameters-and at best might enhance fertility. Dr. Schiff, on the other hand, says repair only those of men to benefit the most.

The latest in medical products for obstetrics and gynecology.

Treat your nonpregnant patient with one of these drug regimens to reduce out-of-control blood loss while she's waiting for the operating room-and she may not need surgery to stop hemorrhage, after all, says this expert. Noting that our standard treatments for this challenging, often overlooked emergency are based on scant data, he assesses your options.

Treat your nonpregnant patient with one of these drug regimens to reduce out-of-control blood loss while she's waiting for the operating room-and she may not need surgery to stop hemorrhage, after all, says this expert. Noting that our standard treatments for this challenging, often overlooked emergency are based on scant data, he assesses your options.

Can a "Delivery Probability Profile" help ob/gyns determine who's most likely to deliver prematurely? One expert in the field examines the evidence.

Women who start or restart combined hormone therapy (HT) or estrogen therapy alone about 15 years after menopause are at greater risk for cardiovascular disease and venous thromboembolism, at least during the first few years of treatment.

It seems a Thai herb that is a relative of the soybean causes estrogen-like effects on vaginal tissue, including alleviating vaginal dryness and dyspareunia, improving vaginal atrophy, and restoring the atrophic vaginal epithelium in healthy postmenopausal women.

It is up to us to dissect out each candidate's position on all the issues we deem important, to assess their integrity, management skills, and leadership qualities that allows us to choose a leader.

Q: A request for Information about Premenopause osteoporosis. I am a 31 year old woman and after the birth of my second child 4 months ago have had back pain. After an x-ray that showed a collapse in one part of my spine, I was sent for a bone density test. At the test they took my height and I was 2 inches shorter. I'm looking for information on pre menopause osteoporosis and can find very little. I would like to be informed on what can be done to help me before I go over my test results with my doctor and to better understand my options. Can you help?

Questions this month have been answered by:R. Wayne Whitted, MD., MPH, OBGYN.net Editorial Advisor

If your patient is in an at-risk group according to the guidelines of the US Preventive Services Task Force, she should be referred for genetic counseling and be considered for testing.

The latest in medical products for obstetrics and gynecology.

Clomiphene is still the first choice to treat infertility and the gold standard for women with PCOS, argues this expert. He critiques research that suggests metformin is superior and discusses the reason two key trials yielded such starkly different results.

Two important studies have addressed this question. A closer look at each will help clinicians make an informed decision that's in each patient's best interest.

Now that laparoscopy during pregnancy is no longer considered too dangerous, should you remove a mass this way-and if so, when?

Now that laparoscopy during pregnancy is no longer considered too dangerous, should you remove a mass this way-and if so, when?

It goes without saying that expedient recognition of a rare condition, in and of itself, does not necessarily guarantee a favorable outcome. In situations where a physician exercises questionable judgment and the outcome is less than favorable, however, the door is open for second-guessers and an increased potential for litigation.

Women who undergo hysterectomy are much more likely to require subsequent surgery for stress urinary incontinence (SUI).

In 1994 and 2004 the FDA and the EPA set upper limits on fish consumption by pregnant and lactating women and children.

Coverage of 36th AAGL Congress November 2007, Washington, DC

Coverage of 36th AAGL Congress November 2007, Washington, DC